Haichuang Pharmaceutical Co.
Latest round
- Series C
Last raised
- Sep 2020
Total raised
- $187M
Investors
- 16
About Haichuang Pharmaceutical Co.
, Ltd. is a drug discovery and development company that focuses on therapeutic areas. The company has 10 products under development. In its current product pipeline, HC-1119 is in two Phase III clinical trials for the treatment of desmoid-resistant prostate cancer; HP501 for the treatment of hyperuricemia and gout has completed a Phase II clinical trial; HP558, a potential therapeutic agent for gastrointestinal tumors, has completed a Phase I clinical trial in Europe and a Phase II clinical trial application has been approved by the NMPA; and HP518, an oral PROTAC agent for AR, is in Phase I clinical trial in Australia. The company has four technology platforms including PROTAC targeted protein degradation technology platform, deuterated drug research and development platform, targeted drug discovery and verification platform, and lead compound optimization and screening platform.
Who invested in Haichuang Pharmaceutical Co.
16 investors across 2 rounds
See all investors in Haichuang Pharmaceutical Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Haichuang Pharmaceutical Co.
Who invested in Haichuang Pharmaceutical Co.?
Haichuang Pharmaceutical Co. has 16 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Haichuang Pharmaceutical Co. raised?
Haichuang Pharmaceutical Co. has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Haichuang Pharmaceutical Co. last raise money?
Haichuang Pharmaceutical Co.'s most recent round on record is a Series C, in Sep 2020.
What does Haichuang Pharmaceutical Co. do?
Haichuang Pharmaceutical Co. is a pharmaceuticals company.
Where is Haichuang Pharmaceutical Co. headquartered?
Haichuang Pharmaceutical Co. is headquartered in Chengdu, China.
Which VCs invest in companies like Haichuang Pharmaceutical Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back pharmaceuticals companies at Haichuang Pharmaceutical Co.'s stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series C
Raising like Haichuang Pharmaceutical Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.